Luxamend

Luxamend is a prescription topical wound cream developed and marketed by Journey Medical Corporation, a subsidiary of Fortress Biotech. Formulated as a water-based emulsion, it is designed to manage various dermatological conditions by providing a moist healing environment that facilitates the natural recovery process of the skin. It is indicated for use on superficial wounds, minor cuts and scrapes, dermal ulcers, donor sites, first- and second-degree burns (including sunburns), and radiation dermatitis. The product was launched in July 2016 as part of Journey Medical's initial dermatology portfolio and functions primarily as a protective barrier rather than through a specific pharmacological active ingredient.

Brand names

Luxamend